Combination inhaled steroid and long-acting beta-agonist versus tiotropium for chronic obstructive pulmonary disease

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Faculty Opinions recommendation of Combined corticosteroid and long-acting beta₂-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718170810.793489148 ◽

2014 ◽

Author(s):

Alice Turner ◽

Stan Ejiofor

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease

10.1002/14651858.cd006829 ◽

2007 ◽

Cited By ~ 4

Author(s):

Luis Javier Nannini ◽

Christopher J Cates ◽

Toby J Lasserson ◽

Phillippa Poole

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Beta Agonists ◽

Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review

Expert Review of Respiratory Medicine ◽

10.1080/17476348.2019.1665514 ◽

2019 ◽

Vol 13 (11) ◽

pp. 1087-1094 ◽

Cited By ~ 1

Author(s):

Paolo Solidoro ◽

Filippo Patrucco ◽

Diego Bagnasco

Keyword(s):

Pulmonary Disease ◽

Fixed Combination ◽

Beta Agonist ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease

Cureus ◽

10.7759/cureus.19168 ◽

2021 ◽

Author(s):

Mizuki Yuasa ◽

Yosuke Tanaka ◽

Tohru Tanaka ◽

Takeru Kashiwada ◽

Namiko Taniuchi ◽

...

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Agonist Therapy ◽

Muscarinic Antagonist ◽

Long‐Acting Beta‐Agonist Use is Associated with Lower Carotid Artery Stiffness and Greater Carotid Artery Compliance in Individuals with Chronic Obstructive Pulmonary Disease

The FASEB Journal ◽

10.1096/fasebj.2018.32.1_supplement.843.14 ◽

2018 ◽

Vol 32 (S1) ◽

Author(s):

Rachel E. Luehrs ◽

Kerrie L. Moreau ◽

Alejandro P. Comellas ◽

Howard D. Weinberger ◽

James D. Crapo ◽

...

Keyword(s):

Carotid Artery ◽

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Artery Stiffness ◽

Long Acting ◽

Carotid Artery Compliance

Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012066.pub2 ◽

2017 ◽

Cited By ~ 18

Author(s):

Nobuyuki Horita ◽

Atsushi Goto ◽

Yuji Shibata ◽

Erika Ota ◽

Kentaro Nakashima ◽

...

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Muscarinic Antagonist ◽

Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for stable chronic obstructive pulmonary disease

10.1002/14651858.cd012066 ◽

2016 ◽

Cited By ~ 2

Author(s):

Nobuyuki Horita ◽

Atsushi Goto ◽

Erika Ota ◽

Kentaro Nakashima ◽

Kenjiro Nagai ◽

...

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Muscarinic Antagonist ◽

Clinical And Economic Burden Of Asthma And Chronic Obstructive Pulmonary Disease In The Uk: Impact Of Critical Inhaler Errors With Inhaled Corticosteroid + Long-Acting Beta Agonist Fixed-Dose Combinations

Value in Health ◽

10.1016/j.jval.2014.03.1016 ◽

2014 ◽

Vol 17 (3) ◽

pp. A174 ◽

Cited By ~ 2

Author(s):

A. Lewis ◽

M. Blackney ◽

S. Torvinen ◽

A. Plich

Keyword(s):

Pulmonary Disease ◽

Economic Burden ◽

Beta Agonist ◽

Fixed Dose ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Long Acting ◽

The Uk

CARDIOVASCULAR OUTCOMES WITH AN INHALED LONG-ACTING BETA AGONIST AND CORTICOSTEROID IN PATIENTS WITH MODERATE CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND HEIGHTENED CARDIOVASCULAR RISK: THE SUMMIT TRIAL

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(16)31918-0 ◽

2016 ◽

Vol 67 (13) ◽

pp. 1917

Author(s):

Robert D. Brook ◽

Julie Anderson ◽

Peter Calverley ◽

Bartolome Celli ◽

Courtney Crim ◽

...

Keyword(s):

Cardiovascular Risk ◽

Pulmonary Disease ◽

Cardiovascular Outcomes ◽

Beta Agonist ◽

Chronic Obstructive ◽

Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

10.1002/14651858.cd006826 ◽

2007 ◽

Cited By ~ 14

Author(s):

Luis Javier Nannini ◽

Christopher J Cates ◽

Toby J Lasserson ◽

Phillippa Poole

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Inhaled Steroids ◽